Filing Details

Accession Number:
0000899243-18-016102
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-11 20:00:42
Reporting Period:
2018-06-07
Accepted Time:
2018-06-11 20:00:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896262 Amedisys Inc AMED Services-Home Health Care Services (8082) 113131700
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673554 L David Kemmerly 3854 American Way, Suite A
Baton Rouge LA 70816
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-07 6,000 $27.35 24,028 No 4 M Direct
Common Stock Disposition 2018-06-07 4,300 $78.69 19,728 No 4 S Direct
Common Stock Disposition 2018-06-07 1,700 $79.86 18,028 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-06-07 6,000 $0.00 6,000 $27.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,375 2018-05-01 2025-05-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 349 Indirect Through 401(k) Plan
Footnotes
  1. The total amount of shares beneficially owned includes 176 shares held in an employee stock purchase plan account.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.40 to $79.36, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.43 to $80.30, inclusive.
  4. The information in this report is based on a plan statement dated as of March 31, 2018.
  5. On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2015 were met, resulting in vesting of the option as to 9,375 shares (the "2015 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2015 Tranche Options vested on May 1, 2016, one-third of the 2015 Tranche Options vested on May 1, 2017 and one-third of the 2015 Tranche Options vested on May 1, 2018.